System and method for reducing tricuspid regurgitation

Information

  • Patent Grant
  • 11890193
  • Patent Number
    11,890,193
  • Date Filed
    Wednesday, October 28, 2020
    3 years ago
  • Date Issued
    Tuesday, February 6, 2024
    3 months ago
Abstract
A first anchor is anchored inside a coronary sinus of a heart of a subject. A second anchor can be driven into a tricuspid annulus of the heart. A distal portion of the second anchor can be disposed adjacent and parallel to a center portion of the second anchor. The second anchor can be seated against a surface of the annulus, for example, such that (i) the distal portion is disposed perpendicular to the center portion, (ii) the center portion extends through the annulus, and (iii) a proximal portion of the second anchor is disposed in the atrium. A distance between the first and second anchors can be reduced by applying tension to a tensioning member coupled to the first anchor and the proximal portion of the second anchor. Other embodiments are also described.
Description
TECHNICAL FIELD

The present teachings generally relate to tissue anchor systems and uses thereof in treating tricuspid regurgitation.


BACKGROUND

Tricuspid valve diseases relate to conditions in which the valve between the two right heart chambers (i.e., the right ventricle and the right atrium) doesn't function properly and these diseases often occur with other heart valve problems. Examples of tricuspid valve diseases include tricuspid valve regurgitation, tricuspid valve stenosis, tricuspid valve atresia, and the Ebstein's anomaly. In the tricuspid valve regurgitation, the tricuspid valve doesn't close properly and blood flows back into the right atrium; in the tricuspid valve stenosis, the tricuspid valve is narrowed and reduces the amount of blood flowing into the right ventricle; in the tricuspid atresia, a congenital heart disease, a solid wall of tissues blocks the blood from flowing between the two right heart chambers; and in the Ebstein's anomaly, a malformed tricuspid valve situates at a position lower than the normal position in the right ventricle and causes blood to flow back into the right atrium. There are other tricuspid valve diseases generally known to a person with ordinary skill in the art and these tricuspid valve diseases are also included in the present teachings.


A tricuspid valve disease can be corrected by an annuloplasty ring. In some instances, this device is preferred for surgically repairing a defective tricuspid valve. An annuloplasty ring is an anatomically-correct three-dimensional (3D) ring and can flexibly conform to the heart valve opening. This ring is implanted into a defective tricuspid valve and reduces the valve opening. Properly implanted, an annuloplasty ring allows the valve to open and close properly.


Tricuspid valve repair surgeries can be done in one of the following two ways: a minimally invasive surgery or an open-heart surgery. A minimally invasive method involves making a small incision in the upper or lower chest and inserting a valve repairing system/device percutaneously. After the valve is repaired, the incision may be closed with dissolving sutures. In some minimally invasive techniques the initial incision or puncture can be allowed to heal without sutures. In this event any bleeding is stopped with manual compression following the procedure. Comparing to an open-heart surgery, advantages of a minimally invasive approach include a shorter recovery time, less post-operation pain, and earlier return to work and normal daily activities.


However, there are drawbacks in either procedures and therefore needs still exist for repairing a diseased tricuspid valve with alternative approaches.


SUMMARY

One aspect of the present teachings provides a percutaneous repair system for reducing a tricuspid annulus circumference. The system comprises a first anchor configured to be deployed inside the coronary sinus, and a second anchor configured to be deployed across the tricuspid annulus. The system further comprises a first tensioning member configured to apply tension to the first anchor with a fixed end connecting to the first anchor and a free end; and a second tensioning member configured to apply tension to the second anchor with a fixed end connecting to the second anchor, and a free end. The system further comprises a lock member joining the free ends of both first and second tensioning members. The lock member is configured to maintain the tension on both the anchors.


Another aspect of the present teachings provides a percutaneous repair system for reducing a tricuspid annulus circumference. The system comprises a first anchor configured to be deployed inside the coronary sinus, and a second anchor configured to be deployed across the tricuspid annulus. The system further comprises a first tensioning member configured to apply tension to the first anchor with a first end connecting to the first anchor and a second end joining a lock member. The second anchor is configured to slide over the first tensioning member. The first tensioning member is configured to apply tension to the first anchor, and the lock member is configured to maintain the tension.


Another aspect of the present teachings provides a percutaneous repair system for reducing a tricuspid annulus circumference. The system comprises a first anchor configured to be deployed inside the coronary sinus and a second anchor configured to be deployed across the tricuspid annulus. The system further comprises a first distance between the first and second anchors and a second reduced distance between the first and second anchors.


Another aspect of the present teachings provides a method for percutaneously reducing the circumference of a tricuspid annulus. This method comprises implanting a first anchor into the coronary sinus and implanting a second anchor across the tricuspid annulus. In various embodiments, each of the first and second anchors connects to a tensioning member. The method further comprises applying tension to both the tensioning members so as to reduce the distance between the first and second anchors from a first distance to a second distance. The method further comprises implanting a locking member to secure the second distance between the first and second anchors. The method further comprises reducing the circumference of the tricuspid valve by tensioning both the tensioning members.





BRIEF DESCRIPTION OF THE DRAWINGS


FIG. 1 is a perspective view of an embodiment of the present teachings where a vascular anchor and an annulus anchor deployed at a treatment location, and tension is applied to both the anchors deployed across the tricuspid annulus in accordance with the present teachings.



FIG. 2 is a perspective view of an exemplary vascular anchor delivery system percutaneously inserted into the coronary sinus in accordance with the present teachings.



FIGS. 3A-3B are embodiments of an exemplary vascular anchor (12) in its delivery profile and attached to a delivery system in accordance with the present teachings.



FIG. 4 is an embodiment of an exemplary vascular anchor in its deployed profile in accordance with the present teachings.



FIG. 5 is a perspective view of an exemplary vascular anchor deployed inside the coronary sinus in accordance with the present teachings.



FIG. 6 is a perspective view of an exemplary wire positioned across the annulus in accordance with the present teachings.



FIG. 7 is a perspective view of an exemplary annulus anchor deployed inside the right ventricle in accordance with the present teachings.



FIG. 8 is an embodiment of an exemplary annulus anchor in its deployed profile in accordance with the present teachings.



FIG. 9A is an embodiment of an exemplary annulus anchor in its delivery profile and attached to a delivery system in accordance with the present teachings.



FIG. 9B is an embodiment of an exemplary annulus anchor in its deployed profile in accordance with the present teachings.



FIG. 10 is a perspective view of an embodiment of the present teachings where tension is applied to both a deployed vascular anchor and a deployed annulus anchor in accordance with the present teachings.



FIG. 11 is a perspective view of an embodiment of the present teachings where a deployed locking member joins both the tensioning members of a deployed vascular anchor and a deployed annulus anchor in accordance with the present teachings.



FIG. 12 is another perspective view of an exemplary positioning wire being placed across the annulus inside the right ventricle in accordance with the present teachings.



FIG. 13 is another perspective view of an exemplary annulus anchor deployed inside the right ventricle in accordance with the present teachings.



FIG. 14 is another perspective view of an embodiment of the present teachings where a locking member is deployed in accordance with the present teachings.



FIG. 15 is another perspective view of an exemplary vascular anchor deployed inside the right ventricle in accordance with the present teachings.



FIG. 16 is another perspective view of an exemplary vascular anchor deployed inside the right ventricle in accordance with the present teachings.



FIG. 17 is another perspective view of an embodiment of the present teachings where a locking member is deployed in accordance with the present teachings.



FIG. 18 is an embodiment of an exemplary vascular anchor in its deployed profile in accordance with the present teachings.



FIG. 19 is an embodiment of an exemplary vascular anchor in its deployed profile in accordance with the present teachings.





DETAILED DESCRIPTION

Certain specific details are set forth in the following description and figures to provide an understanding of various embodiments of the present teachings. Those of ordinary skill in the relevant art would understand that they can practice other embodiments of the present teachings without one or more of the details described herein. Thus, it is not the intention of the Applicant(s) to restrict or in any way limit the scope of the appended claims to such details. While various processes are described with reference to steps and sequences in the following disclosure, the steps and sequences of steps should not be taken as required to practice all embodiments of the present teachings.


As used herein, the term “lumen” means a canal, a duct, or a generally tubular space or cavity in the body of a subject, including a vein, an artery, a blood vessel, a capillary, an intestine, and the like. The term “lumen” can also refer to a tubular space in a catheter, a sheath, a hollow needle, a tube, or the like.


As used herein, the term “proximal” shall mean close to the operator (less into the body) and “distal” shall mean away from the operator (further into the body). In positioning a medical device inside a patient, “distal” refers to the direction away from a catheter insertion location and “proximal” refers to the direction close to the insertion location.


As used herein, the term “wire” can be a strand, a cord, a fiber, a yarn, a filament, a cable, a thread, or the like, and these terms may be used interchangeably.


As used herein, the term “sheath” may also be described as a “catheter” and, thus, these terms can be used interchangeably.


Unless otherwise specified, all numbers expressing quantities, measurements, and other properties or parameters used in the specification and claims are to be understood as being modified in all instances by the term “about.” Accordingly, unless otherwise indicated, it should be understood that the numerical parameters set forth in the following specification and attached claims are approximations. At the very least and not as an attempt to limit the application of the doctrine of equivalents to the scope of the attached claims, numerical parameters should be read in light of the number of reported significant digits and the application of ordinary rounding techniques.


The present teachings relate to devices and methods for treating a tricuspid valve regurgitation percutaneously. Although referring to FIGS. 1 to 19, a person with ordinary skill in the art would recognize that the figures and description thereto refer to various embodiments of the present teachings and, unless indicated otherwise by their contexts, do not limit the scope of the attached claims.


An aspect of the present teachings relates to methods of reducing the circumference of a tricuspid valve (2). For example, now referring to FIG. 1, the circumference of a tricuspid valve (2) can be reduced by deploying an anchoring system (10) with a vascular anchor (12) deployed inside the coronary sinus and an annulus anchor (14) engaging at a location along the anterior or posterior annulus. Each anchor is attached with a flexible tensioning member (16, 18). Tension is then applied to both the anchors, and a lock member (20) secures free ends of both the flexible tensioning members (16, 18) while maintaining the tension at a pre-defined level. Upon deployment of this anchor system (10), the tricuspid annulus (8) is pulled toward the inferior portion of the atrial septum (4). Depending on the location of the annulus anchor (14), a portion of the annulus could fold. Alternatively, the overall shape of the annulus could change. Both the results would lead to more coaptation of the tricuspid leaflets and, therefore, reduce or eliminate the tricuspid valve regurgitation jet. As a result, the tricuspid valve (2) could be fully closed during a right ventricular systole.



FIGS. 2-4 illustrate the deployment of a vascular anchor (12) inside the coronary sinus (CS) according to the present teachings. According to some embodiments, a vascular anchor delivery system (30) gains access through a standard right heart catheterization procedure, for example, through the femoral vein, the inferior vena cava, and the right atrium. Once inside the right atrium, the vascular anchor delivery system (30) extends further through the opening of the coronary sinus at the inferior portion of the atrial septum (4). In one embodiment, the vascular anchor (12) is then deployed inside the coronary sinus, 15-25 mm from its right atrium opening.



FIG. 2 illustrates an alternative embodiment of delivering a vascular anchor (12) inside the coronary sinus. In this embodiment, the access to the right atrium is gained by entering the jugular vein; extending through the right brachiocephalic vein and the superior vena cava (6); and reaching the right atrium. Once inside the right atrium, the delivery system further extends downwardly towards the inferior region of the atrial septum (4), and enters the opening of the coronary sinus. Similarly, once inside, a vascular anchor (12) is then deployed inside the coronary sinus.



FIG. 5 illustrates a vascular anchor (12) deployed inside the coronary sinus, where the vascular anchor (12) secures itself to its surrounding tissue, and the vascular anchor (12) connects to a flexible tensioning member (18) which extends proximally outside of the coronary sinus. As shown in FIG. 5, a portion of the flexible tensioning member (18) is inside the right atrium, and the flexible tensioning member (18) further extends proximally with its proximal end extending outside of the body.



FIGS. 3-4 further illustrate an embodiment of the delivery system (30, 30′). The delivery system (30, 30′) includes a delivery sheath (32, 32′) that holds a vascular anchor (12) in its delivery profile. The delivery system (30, 30′) could further includes a mechanism (34, 34′) that can be used to transport a vascular anchor (12), for example from the proximal end of the delivery sheath (32, 32′) to the distal end of the delivery sheath (32, 32′), or push the vascular anchor (12) distally out of the distal end of the delivery sheath (32, 32′).


According to some embodiments of the present teachings, the vascular anchor (12) deployed inside the coronary sinus has an elongated body which is suitable for being positioned inside the vasculature. In some embodiments, the vascular anchor (12) is configured to collapse into a radially profile which is suitable to be delivered percutaneously by a delivery system (30, 30′) as described above, for example, as shown in FIGS. 3A-3B. In some embodiments, the vascular anchor (12) expands radially during the deployment. In some embodiments, as the vascular anchor (12) expands radially, the overall longitudinal length of the vascular anchor (12) shortens, for example, as shown in FIG. 4.


In some embodiments, the vascular anchor (12) is to be delivered through a vascular anchor delivery mechanism (34, 34′). The delivery mechanism (34, 34′) is designed to engage the vascular anchor (12) during its delivery, which allows the vascular anchor (12) to be pushed distally, pulled proximally, or held steady while the vascular anchor (12) transitions from its collapsed delivery profile into its radially expanded deployed profile. The engagement between the delivery mechanism (34, 34′) and the vascular anchor (12) is configured to be detachable, for example, at the distal end (42) of the vascular anchor (12), at the proximal end (44) of the vascular anchor (12), or through a central lumen (46) of the vascular anchor (12). The connecting flexible tensioning member (18) is configured to be disposed inside the delivery mechanism (34, 34′), or alternatively, along the delivery mechanism (34, 34′) while locating inside the delivery sheath (32, 32′).


In some embodiments, the vascular anchor (12) is made from a super-elastic or shape-memory material such as Nitinol. The super-elastic material would allow the vascular anchor (12) to be advanced to the implantation site in a collapsed configuration. Simply unsheathing the vascular anchor (12) could then allow the vascular anchor (12) to expose, expand, and contact the walls of the vasculature, for example, the coronary sinus. According to one embodiment of the present teachings, as shown in FIG. 3A, the delivery system (30) includes an outer sheath (32) and an inner catheter (34) which resides inside the lumen of the outer sheath (32). The inner catheter (34) resides inside the collapsed lumen of the vascular anchor (12) and is configured to engage the vascular anchor (12) when the vascular anchor (12) is in its collapsed state by a known mechanism to those skilled in the field, such as a simple hook or groove mechanism. In some embodiments (not shown), the inner catheter (34) features an inner lumen which is configured to allow a positioning wire to pass through the inner lumen. In some embodiments, the inner lumen of the inner catheter (34) is configured to allow a 0.3-0.9 mm interventional wire to pass through. Optionally, the positioning wire is configured to locate the coronary sinus. A vascular delivery system (30) then tracts over the positioning wire to the intended treatment location.


In other embodiments, the vascular anchor (12) is made of a plastically deformable material such as stainless steel, cobalt chromium, or similar materials. In some embodiments, the vascular anchor (12) is made from a polymeric material such as PET or other plastically deformable material. In some embodiments, the deformable anchor (12) includes a collapsed deployment configuration and an expanded implanting configuration. In the collapsed deployment configuration, the anchor (12) is collapsed around a deflated endovascular balloon, as shown in FIG. 3B. The endovascular balloon may be made of any of the materials known to one with ordinary skill in the current state of the art, including PET or Mylar, polyurethane, or similar materials. In some embodiments (not shown in FIG. 3B), the endovascular balloon is defined by an annular inflation space with an internal diameter that is configured to allow passage of an interventional wire. In some embodiments, the vascular anchor (12) is collapsed on the annular balloon and held in a collapsed state by an outer sheath (32′). The delivery system (30′) including the outer sheath (32′), the annular balloon (36′) and a balloon catheter (34′), the vascular anchor (12), and the positioning wire is delivered into the coronary sinus. (Similar to descried above, the positioning wire is used to locate the coronary sinus.) Once the vascular anchor is implanted, the outer sheath (32′) is removed or partially retracted, exposing the vascular anchor (12), along with the inflation balloon (36′). The balloon is then inflated, causing the vascular anchor (12) to deform, expand, and engage the inner surface of the vasculature.


As shown in FIG. 4, according to some embodiments, the vascular anchor (12) has a generally tubular profile with a hollow surface structure, which allows an easy radial expansion of the vascular anchor (12) during the deployment. The vascular anchor (12) includes a distal end (42), a proximal end (44), and a longitudinal lumen (46), which does not impede blood flow.


According to some embodiments, the overall length of the vascular anchor (12) in its deployed profile is 15-25 mm. According to some embodiments, the general size of the vascular anchor (12) is 12-18 mm in diameter. According to some embodiments, the vascular anchor (12) has a generally tubular deployed profile. In another embodiment, the vascular anchor (12) has a conical or frustro-conical deployed configuration with its proximal end having a larger general diameter, and the distal end having a relatively smaller diameter. One skilled in the art should understand that the overall size of a vascular anchor (12) is designed for even distribution of the force to the surrounding tissue. As a result, it could vary based on an individual patient.


In another embodiment, the proximal end of the anchor is positioned approximately to the ostium (6) of the coronary sinus. In another embodiment, the proximal end of the vascular anchor (12) is positioned significantly into the coronary sinus. In a particular embodiment, the vascular anchor (12) is advanced until it resides along the posterior aspect of the left heart approximately 20-80 mm into the coronary sinus, for example the proximal end of the anchor is positioned 15 mm from the ostium and inside the coronary sinus A clinician should determine the optimum implantation location based on each patient's symptom and anatomy. Thus, what has been disclosed here is merey an example, and should not be viewed as limiting.


In some embodiments of the present teachings, the vascular anchor (12) has a hollow surface structure along its tubular surface. As illustrated, each hollowed surface structure is separated by struts with wavy or zigzag patterns. A wavy and zigzag pattern allows the tubular body of the anchor to expand radially. According to some embodiments, the vascular anchor (12) with a hollow surface structure is fabricated by laser-cutting or acid-etching a pattern into a preformed tube, then shape-setting the anchor to the intended deployed configuration. In such embodiments, the vascular anchor (12) with a hollow surface structure is formed by slotting a hollow tube, for example, with a machining laser, a water drill, or other methods, and expanding the slotted hollow tube to form an open structure. Alternatively, a vascular anchor (12) with a hollow surface structure can be formed with a woven, knitted, or braided tubular metallic fabrics made out of metallic strands. The term “strand” used herein can be wires, cords, fibers, yarns, filaments, cables, threads, or the like, and these terms may be used interchangeably.


A vascular anchor (12) of the present teachings is configured to engage the surrounding tissues when the vascular anchor (12) is deployed. According to one embodiment, once exiting from the delivery sheath, the vascular anchor (12) expands radially so that it secures itself to the surrounding tissues. In some embodiments, the vascular anchor (12) is made of a thermal shape memory material so that once exposed inside the blood stream, the vascular anchor (12) expands radially by itself. In another embodiment, the vascular anchor (12) is expanded by a vascular balloon.


Once deployed inside a vasculature, the vascular anchor (12) expands and secures itself at a location inside the coronary sinus without migrating along the length of the vein. In some embodiments, the vascular anchor (12) secures to the surrounding tissues through interference between its tubular surface and the vasculature. In another embodiment, the vascular anchor (12) has tissue engagement features such as barbs, hooks. In some embodiments, the vascular anchor (12) is designed to locally expand the coronary sinus significantly. In some embodiments, the vascular anchor (12) when deployed causes the internal diameter of the vascular anchor (12) to increase by 50%. Due to the anatomical structure of the heart, it is sometimes preferred that the tissue engagement feature is oriented facing inward of the heart.


In some embodiments, the vascular anchor (12) is configured to engage the internal diameter of the coronary sinus near the coronary sinus ostium (6). In some embodiments, the vascular anchor (12) is configured to engage the Eustachian valve near the coronary sinus ostium (6). In some embodiments, the vascular anchor (12) completely punctures the ridge of tissue separating the coronary sinus ostium (6) from the right atrium. This ridge of tissue may be referred to as a Eustachian valve. In patients with significant tricuspid regurgitation, this tissue ridge is often enlarged or at least more pronounced by the dilation of the surrounding heart chambers. In yet other embodiments, the vascular anchor (12) is implanted into one of the venous branches extending from the coronary sinus.


As shown in FIG. 5, the deployed vascular anchor (12) is attached with a flexible tensioning member (18). The distal end of the flexible tensioning member (18) joins the vascular anchor (12). The proximal end of the flexible tensioning member (18) extends proximally and eventually exits to the outside of the body and remains in the control of a clinician. As shown in FIG. 5, before the treatment is completed, a portion of the flexible tensioning member (18) is exposed inside the right atrium. According to some embodiments, the flexible tensioning member (18) attaches to a proximal end of the vascular anchor (12). According to an alternative embodiment, the flexible tensioning member (18) attaches to any portion of the anchor. One skilled in the art should understand that the connection between the flexible tensioning member (18) and the vascular anchor (12) should be strong enough to withstand a certain amount of strain applied later. In some embodiments the vascular anchor (12) is made from a laser cut Nitinol tube which has been formed into a stent-like structure. An eyelet may be cut into the stent like structure, allowing the attachment of a suture material to the eyelet by a simple knot. In other embodiments, a suture is attached to the vascular anchor (12) by swaging, crimping, gluing, pinching, or clamping the suture to a feature of the vascular anchor (12).



FIG. 5 illustrates an embodiment of the present teachings, where the flexible tensioning member (18) attachment point is at or approximately to the ostium (6) of the coronary sinus. As shown, the flexible tensioning member (18) attaches to the vascular anchor (12) on its outside edge of the curve, further away from the tricuspid valve.


Now referring to FIGS. 6-8, where an annulus anchor (14) is deployed at a location along the tricuspid annulus (8). As shown in FIG. 8, the annulus anchor (14) has a distal portion (52), which is deployed against the right ventricle side of the annulus, a center portion (54), which is positioned through the annulus (8), and a proximal portion (56), which is positioned inside the right atrium. A second flexible tensioning member (16) attaches to the proximal portion of the annulus anchor (14). The flexible tensioning member (16) also has a distal end attaching to the annulus anchor (14), and a proximal end that extends proximally through the annulus anchor delivery system (60) and eventually outside of the body, and remains in control by a clinician. As shown in FIG. 8, once the annulus anchor (14) is deployed at a treatment location, a portion of the second flexible tensioning member (16) is exposed inside the right atrium.


Deployment of the annulus anchor (14) starts with an annulus anchor delivery system (60) gaining access to the right atrium. FIG. 6 illustrates an embodiment where the access to the right atrium is gained by the annulus anchor delivery system (60) entering the jugular vein, and extending through the right brachiocephalic vein and the superior vena cava, and reaching the right atrium. Alternative accesses to the right atrium could be gained through a standard right heart catheterization procedure, similar to those described above, for example, with the delivery system entering through the femoral vein, the inferior vena cava, and the right atrium.


Once inside the right atrium, the annulus anchor delivery system (60) further extends downwardly towards the tricuspid annulus (8). After an implant location is identified, a locating wire (68) punctures the annulus (8) to create an aperture. A tissue anchor is deployed at the location. Methods of locating and placing a locating wire (68) at a selected implant location is disclosed in U.S. patent application Ser. No. 14/190,732 (now U.S. Pat. No. 9,724,084), filed on Feb. 26, 2014, entitled “Devices and Methods for Percutaneous Tricuspid Valve Repair,” the content of which is incorporated by reference herein in its entirety.


Once an implant location is identified and marked with a locating wire (68), as shown in FIG. 6, a locating wire (68) extends from the right atrium, across the tricuspid annulus (8), and into the right ventricle. An annulus anchor (14) is then deployed across the aperture created by the locating wire (68). Unlike the deployment of the vascular anchor (12), the annulus anchor (14) is deployed in a step-wise process. As the distal end of the annulus anchor delivery system (60) extends through the aperture into the right ventricle, the distal end of the annulus anchor (14) is pushed outside of the distal end of the annulus anchor delivery system (60). The distal portion (52) of the annulus anchor (14) assumes its radially expanded profile, as shown in FIG. 7. The delivery system holds the rest of the annulus anchor (14), then is pulled proximally so that the distal portion (52) of the annulus anchor (14) is positioned against the annulus tissue. The delivery system (60) is then pulled further proximally to expose the center portion (54) of the annulus anchor (14), and the proximal portion (56) of the annulus anchor (14).



FIGS. 9A-9B illustrate an embodiment of an annulus anchor (14) of the present teachings. As shown in FIG. 9B, the annulus anchor (14) has a large elongated distal portion (52), which is designed to be pivotable at the location where it joins the center portion (54) of the annulus anchor (14). During delivery (as shown in FIG. 9A), the distal portion (52) of the anchor (14) pivots radially so that it aligns with the center portion (54) of the anchor (14). The entire annulus anchor (14) is configured to be slidably disposed inside the delivery sheath (62). FIG. 9A further illustrates that the annulus anchor delivery system (60) also includes an outer sheath (62) and an inner catheter (64) which resides inside the lumen of the outer sheath (62). The distal end of the inner catheter (64) contacts the annulus anchor (14) and is configured to push the annulus anchor (14) distally, or prevent annulus anchor (14) from sliding proximally inside the delivery sheath (62). According to some embodiments, simply unsheathing the delivery sheath (62), or pushing the delivery catheter (64) distally while holding the delivery sheath (62) steady allows the annulus anchor (14) to be exposed and expand.


According to some embodiments, upon deployment, the distal portion (52) of the annulus anchor (14) pivots automatically and assumes its profile perpendicular to the center portion (54) of the anchor (14), as shown in FIG. 9B. Upon deployment, the distal portion (52) of the annulus anchor (14) is positioned against the ventricular side of the annulus. According some embodiments of the present teachings, the deployed annulus anchor (14) is deployed at the anterior-posterior commissure or 3 mm in each direction of this commissure.


The center portion (54) of the annulus anchor (14) also has an elongated profile. The center portion (54) of the annulus anchor (14) pivotably joins the distal portion (52) of the anchor (14), and, in some embodiments, pivotably attaches to the proximal portion (56) of the anchor (14). As shown in FIG. 9A, during delivery, the center portion (54) of the anchor (14) aligns with the distal portion (52) of the anchor (14), and is slidably disposed inside the delivery sheath (62). During deployment, at least a portion of, sometimes the entire, center portion (54) of the annulus anchor (14) is also deployed along with the distal portion (52) of the anchor. Specifically, as the delivery system (60) is pulled back proximally, and the distal portion (52) of the anchor (14) is positioned against the annulus, the center portion (54) of the anchor (14) is positioned through the aperture across the annulus (8).


According to some embodiments, the proximal portion (56) of the anchor (14) is an extension of the center portion (54) of the anchor (14). Thus, the connection between the center portion (54) and the proximal portion (56) is rigid. One skilled in the art should understand, for example, that the proximal portion (56) of the anchor (14) can adopt other profiles, for example, those similar to the profiles of the distal portion (52). Once released from the delivery system (60), the proximal portion (56) of the annulus anchor (14) can also pivot and assume its expanded profile, sometimes similar to the distal portion (52) of the annulus anchor (14).


Many other shapes and profiles could be adopted for the purpose of this application, including, for example, the annulus anchors (14) disclosed in U.S. patent application Ser. No. 12/273,670 (now U.S. Pat. No. 8,951,286), filed on Nov. 19, 2008, entitled “Tissue Anchor and Anchoring System,” U.S. patent application Ser. No. 11/174,951 (now U.S. Pat. No. 8,951,285), filed on Jul. 5, 2005, entitled “Tissue Anchor, Anchoring System and Methods of Using the Same,” U.S. patent application Ser. No. 13/777,042 (now U.S. Pat. No. 9,259,218), filed on Feb. 26, 2013, entitled “Tissue Anchor and Anchoring System,” each of which is incorporated by reference herein in its entirety. One skilled in the art should also understand that examples of suitable tissue anchors include, but not be limited to, tissue fasteners, tissue pledgets, or tissue staples etc.


As shown in FIG. 8, the proximal portion (56) of an annulus anchor (14) joins a second flexible tensioning member (16). During delivery, the second flexible tensioning member (16) is slidably disposed within the annulus anchor delivery system (60). As shown in FIG. 8, the distal end of the flexible tensioning member (16) joins the proximal portion (56) of the annulus anchor (14). The proximal end of the flexible tensioning member (16) extends proximally through the delivery system (60) and eventually to the outside of the body, and remains in the control of a clinician. As shown in FIG. 8, before the treatment is completed, a portion of the second flexible tensioning member (16) is located inside the right atrium.



FIGS. 10-11 illustrate an embodiment of a plication procedure of the present teachings, for example, for reducing the circumference of a tricuspid valve annulus (8). Upon deployment of a vascular anchor (12) and an annulus anchor (14) at their intended locations according to the present teachings, the free ends of the tensioning members (16,18) from each anchor (12, 14) are pulled so that the anchors will be drawn towards each other to plicate the tricuspid annulus (8), as shown in FIG. 10. According to some embodiments, once both the vascular and annulus anchors (12, 14) are deployed at their respective locations, there is a first natural distance between the anchors (12, 14). Upon applying tension to both the tensioning members (16, 18) extending from the anchors (12, 14), the distance between the two anchors (12, 14) reduces to a second distance. Doing so, the natural circumference of the tricuspid annulus (8) is reduced. A crimp or other lock member (70) may then be delivered through a lock member delivery system (72) and be used to lock in the desired circumference reduction by crimping onto the tensioning members (12, 14). Upon deploying a lock member (70) in place, the excess tensioning member proximal to the lock member (70) may then be cut and removed from the body. In some embodiments, the reduction from the first natural distance to the second reduced distance is around 25-35 mm. For example, before tension is applied, the distance between both the anchors can be 25-35 mm. Upon tensioning, the distance between the two anchors is between 0-10 mm.


According to some embodiments, as shown in FIG. 11, the lock member (70) and both the tensioning members (16, 18) are located inside the right atrium after the procedure. Since the coronary sinus drains into the right atrium, and its opening locates between the inferior vena cava and the tricuspid valve on the inferior aspect of the interatrial septum (4), by pulling the anterior-posterior commissure toward the septum, in some embodiments, the tricuspid annulus (8) changes it natural shape, resulting in an improved cooptation between the anterior and posterior leaflets with the septal leaflet. In some instances, the plication achieved by the two anchors may bicuspidize the valve, creating two functioning leaflets. In some instances, the plication completely eliminates the posterior leaflet. In some instance, the plication eliminates the posterior leaflet and shortens the effective length of the septal leaflet, for example, the plication may completely obviate the posterior leaflet and may reduce the functional length of the septal leaflet by 10-15 mm.


Suitable lock members include those known in the art and those described in U.S. application Ser. No. 11/753,921 (which published as US 2007/0276437), filed on May 25, 2007, entitled “Lockers for Surgical Tensile Members and Methods of Using the Same to Secure Surgical Tensile Members,” the entire disclosure of which is incorporated herein by reference. With the tensioning members secured by a lock member (not shown), the excess tensioning member(s) proximal to the lock member can be removed by a cutter, including, for example, a cutter disclosed in U.S. patent application Ser. No. 11/935,054 (now U.S. Pat. No. 8,911,461), filed on Nov. 5, 2007, entitled “Suture Cutter and Method of Cutting Suture,” the entire disclosure of which is incorporated herein by reference.


Upon the deployment of the lock member (70) to lock the tensioning members in place, the circumference of the tricuspid annulus (8) is then reduced by some first reduction amount. The reduced tricuspid valve annulus therefore has lower regurgitation and allows the body to remodel.


According to some embodiments, the tensioning member (18) joins the distal end (42) of the vascular anchor (12), such as shown and described herein. One skilled in the art should understand that the tensioning member (18) could also joins the proximal end (44) of the vascular anchor (12). In some embodiments, where a vascular anchor (12) joins the tensioning member (18) at its distal end (42), the reduced tricuspid annulus (8) valve reduces and/or eliminates valve regurgitation. As the body remodels, the right atrial pressure and coronary sinus venous pressure should decrease with the decreased tricuspid valve regurgitation. This positive remodeling allows the previously dilated coronary sinus to shrink in diameter. According to some embodiments of the present teachings, the reduction in diameter of the coronary sinus causes the vascular anchor (12) to elongate, thereby reducing its diameter. As the vascular anchor (12) elongates, its distal end (42) extends further distally to the inside of the coronary sinus, applying additional tension to the tensioning member (18) connected at its distal end. This could supply additional distance reduction between the vascular anchor (12) and annulus anchor (14), thereby plicating the annulus (8) further. This effect further reduces the circumference of the tricuspid annulus (8), and further accelerates the reduction of the tricuspid valve regurgitation. According to some embodiment of the present teaching, the vascular anchor is designed with a pre-set tension limiting mechanism. Once the pre-set tension limit is reached, for example during implantation or sometimes triggered by post procedure coronary sinus remodeling, the vascular anchor will change its shape/form in part or in whole to prevent further tension increase. For example, the proximal portion of the vascular could elongate under excess tension and thereby extend proximally.



FIGS. 12-14 illustrate another embodiment of the present teachings, where both vascular anchor (12) and annulus anchor (14) are joined with one tensioning member (18). In this embodiment, the implantation of the vascular anchor (12) is the same as described before, for example, in relation to FIGS. 2-5. Similar to what has been described, for example, in relation to FIG. 6, a position wire (68) is then placed at a location across the tricuspid annulus (8). With the proximal end of the tensioning member (18) extending from the vascular anchor (12) to the outside of the body. A clinician then slides an annulus anchor (14) over the proximal end of the tensioning member (18), transforms the annulus anchor (14) into its collapsed delivery profile, and assembles it to the distal end portion of the annulus anchor delivery system (60). The annulus anchor delivery system assembly is similar to what has been described above for example in relation to what has been described in FIGS. 9A-9B. This assembly then tracks over the positioning wire (68) and advances distally toward the tricuspid annulus (8) implantation location as shown in FIG. 12.


Continuing referring to FIG. 13, an annulus anchor (14) is then deployed across the tricuspid annulus (8) with its distal portion (52) positioned against the annulus (8) inside the right ventricle, its central portion (54) positioned across the annulus (8), and its proximal portion (56) inside the right atrium. As shown in FIG. 13, the tensioning member (18) has its distal ends fixedly attached to the vascular anchor (12). The annulus anchor (14) has its proximal end slide over the tensioning member (18). By applying tension to the tensioning member (18), the natural distance between the annulus anchor (14) and the vascular anchor (12) is reduced, causing the annulus to plicate and/or bicuspidize. The circumference of the tricuspid annulus (8) is thereby reduced, and tricuspid regurgitation is also reduced.


Upon removing both the position wire (68) and annulus anchor delivery system (60), a tension can be applied by a clinician to the tensioning member (18), thereby pulling two anchors (16, 18) closer to each other, and effectively reducing the circumference of the tricuspid annulus (8). Then, a clinician slides a lock member (70) over the tensioning member's proximal end. Using a lock delivery system similar to what has been described above, a lock member (70) is then deployed against the annulus anchor (14), holding the pre-loaded tension on the tensioning member, maintaining the desired circumference reduction on the tricuspid annulus (8). Upon completion of the procedure, the excess tensioning member is then cut and removed from the body. FIG. 14 illustrates a vascular anchor (12) deployed inside the coronary sinus, an annulus anchor (14) deployed across the tricuspid annulus (8), and one tensioning member connecting both anchors with a lock member (70) maintaining the shortened distance between the two anchors (12, 14).



FIGS. 15-16 further illustrate another embodiment of the present teachings. Similar to the embodiments described in accordance with FIGS. 12-14, the present embodiment also involves a vascular anchor (12) and an annulus anchor (14) joined by one tensioning member (16). In this embodiment, the annulus anchor (14) is deployed first at an identified treatment location. The procedure and methods of identifying an implantation location and deploying an annulus anchor (14) are similar to what has already been described, for example, in accordance with FIGS. 6-8.


With an annulus anchor (14) deployed across tricuspid annulus (8), a tensioning member (16) fixedly joins to the annulus anchor (14) at its proximal end, and extends proximally outside of the body. With the proximal end of the tensioning member (16) extending to the outside of the body, a clinician then slides a vascular anchor (12) over the proximal end of the tensioning member (16), then transforms the vascular anchor (12) into its collapsed delivery profile and assembles it to the distal end portion of the vascular anchor delivery system (30). The vascular anchor delivery system assembly is similar to what has been described above for example in relation to what has been described in FIGS. 3A-3B. Optionally, this assembly then tracks over the positioning wire that is put in place inside the coronary sinus. FIG. 15 illustrates that a vascular anchor delivery system assembly carrying the vascular anchor (12) advances distally, and is placed inside the coronary sinus implantation location.


The vascular anchor (12) is then deployed in accordance with what has been disclosed above. Upon deployment, as shown in FIG. 16, an annulus anchor (14) is positioned across the annulus, a vascular anchor (12) is positioned inside the coronary sinus, and a tensioning member (16) fixedly joins the annulus anchor (14) at its distal end and slides through at least a portion of the vascular anchor (12). The proximal end of the tensioning member (16) extends through at least a portion of the vascular anchor (12), and extends proximally to the outside of the body.


At this point, a tension is applied by a clinician to the tensioning member (16), thereby pulling two anchors (12, 14) closer to each other and effectively reducing the circumference of the tricuspid annulus (8). A clinician then slides a lock member (70) over the proximal end of the tensioning member (16), and uses a lock delivery system similar to what has been described above to deploy a lock member (70) against the vascular anchor (12), holding the pre-loaded tension on the tensioning member (16), maintaining the desired circumference reduction on the tricuspid annulus (8). Upon completion of the procedure, the excess tensioning member (16) is then cut and removed from the body. FIG. 17 illustrates a vascular anchor (12) deployed inside the coronary sinus, an annulus anchor (14) deployed across the tricuspid annulus (8), and one tensioning member connecting both anchors with a lock member (70) maintaining the shortened distance between the two anchors (12, 14).


Although FIGS. 1-17 illustrate embodiments of the tricuspid annulus plication system with one vascular anchor and one annulus anchor, one skilled in the art should understand that a system with one vascular anchor and more than one annulus anchor can also be applied in the treatment, and therefore such systems and uses thereof are within the scope of present teachings.


According to some embodiments, the vascular anchor has a general tubular profile, as illustrated in the figures. The vascular anchor can also have a general conical profile as disclosed above with its proximal end having a larger profile than its distal end. One skilled in the arts should understand that the vascular anchor could take on other profile that is suitable for deploying inside the coronary sinus.



FIGS. 18-19 illustrate other embodiments of a vascular anchor (80, 90) of the present teachings. As illustrated, the vascular anchor (80, 90) has a radially enlarged distal profile (82, 92), a radially enlarged proximal profile (84, 94), and an elongated member (86, 96) connecting both the distal and proximal portions (82, 84, 92, 94). The enlarged distal portion (82, 92) could be in a shape of a cone, a disc, or other suitable profile. Similarly, the enlarged proximal portion (82, 92) could be in a shape of a cone, a disc, or other suitable profile. The elongated member (86, 96) has a smaller radial profile comparing to the distal and proximal portions (82, 84, 92, 94) of the vascular anchor (12). The elongated member (86, 96) connects the distal portion (82, 92) at its distal end, the proximal portion (84, 94) of the vascular anchor ((80, 90)) at its proximal end.


According to some embodiments, the vascular anchor (80, 90) as shown in FIGS. 18-19 are made of one continuous wire. FIG. 18 illustrates an embodiment of the present teachings where, the distal portion (82) of the wire forms a roughly spiral shape. The wire continues from the distal portion (82) of the vascular anchor (80), forms the elongated member (86), and continues toward the proximal portion (84). The proximal portion (84) of the wire also forms a roughly spiral shape. FIG. 19 illustrates another embodiment of the present teachings where, the distal and proximal portions (92, 94) of the wire forms a series of semi-circular turns which are configured to expand the inner diameter of the coronary sinus, the middle portion of the wire forms the elongated member (96) connecting the distal (92) and proximal portions (94) of the vascular anchor (90). One skilled in the art should understand FIGS. 18-19 are merely illustration of two embodiments, the vascular anchor formed of a wire can adopt other shapes and profiles for its distal and proximal portion. And the distal and proximal portions of such vascular anchor can have the same or different profiles.


In some embodiments, the wire used to form such vascular anchor is a super-elastic shape-memory wire. The shape memory wire may be pre-set into a series of large loops. The vascular anchor is delivered in a collapsed profile and once exposed inside the coronary sinus, it resumes it pre-set profile. In some embodiments, the shape memory wire has a diameter of 0.3-0.6 mm.


In one embodiment, a tensioning member (88, 98) joins the distal portion (82, 92) of the vascular anchor (80, 90). In another embodiment, a tensioning member (88, 98) joins the proximal portion of the vascular anchor (80, 90). Yet in another embodiment, the wire that forms the vascular device (80, 90) becomes a tensioning member (88, 98) that joins the vascular anchor and is used for tensioning the device.


According to various embodiments of the present teachings, a radiopaque marker or textured surface is used to make the device visible by using a radiographic imaging equipment such as an X-ray, magnetic resonance, ultrasound or other imaging technique. A marker disclosed herein may be applied to any part of the guide, catheter, or devices disclosed in present teachings. A radiopaque marker can be sewed, adhered, swaged riveted, or otherwise placed and secured on the guide, catheter, and/or devices. The radiopaque marker may be made from a material selected from tantalum, tungsten, platinum, irridium, gold, an alloy thereof, or another material known to those with ordinary skill in the art. The radiopaque marker can also be made from cobalt, fluorione, or another paramagnetic material, or another MR visible material known to those with ordinary skill in the arts. Additionally, a contrast media injected into the atrium, ventricle, or artery may also be used to confirm the positioning under a fluoroscope.


Exemplary methods for treating tricuspid valve regurgitation described herein comprises a number of other steps. One skilled in the art should understand that the sequence of the steps can be changed, or each of steps can be omitted or modified according to each patient's needs. And those modifications should also be considered as within the scope of the present teachings. For example, access to the right atrium is gained by entering the jugular vein according to some embodiments described herein, but one skilled in the art should understand that access to the right atrium can also be achieved by entering the femoral vein and through the inferior vena cava (IVC). In addition, although the tensioning member and tissue anchor, as well as the tensioning member and vascular anchor are described as separate components according to some embodiments, one skilled in the art should understand that the tensioning member and each of the anchor can be part of an integral part. In another example, although the lock member described or incorporated above is a component separate from the tensioning member, one skilled in the art should understand other types of locking mechanisms can also be incorporated, including, for example, a knot that is part of the tensioning member and self-tightens as the tensioning member is pulled by a clinician. The present teachings also disclose certain exemplary delivery catheters/sheathes for delivering a tissue anchor, a vascular anchor, or/and a lock, and for removing a part of a tensioning member. A person skilled in the art should understand that some or all of the delivery catheters/sheathes can be combined, all of which are within the scope of this disclosure. Thus, any of the embodiments described herein should not be used to limit the scope of the invention.


Unless otherwise defined, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this present teachings belong. Methods and materials similar or equivalent to those described herein can be used in the practice of the present teachings. In case of conflict, the specification, including definitions, controls. In addition, the materials, methods, and examples are illustrative only and not intended to be limiting.

Claims
  • 1. A method for use at a tricuspid valve of a heart of a subject, the tricuspid valve having an annulus and being disposed between a right atrium and a right ventricle of the heart, the heart having a coronary sinus, and the method comprising: using a first delivery device: transluminally advancing a first anchor to the coronary sinus, andanchoring the first anchor inside the coronary sinus;using a second delivery device: transluminally advancing a second anchor to the right atrium, the second anchor including a proximal portion, a center portion, and a distal portion that is pivotally coupled to the center portion, andanchoring the second anchor at a site that is across the annulus from the coronary sinus by: while the distal portion is disposed adjacent and parallel to the center portion, driving the distal portion from the right atrium, through the annulus at the site, and into the right ventricle,seating the distal portion against a ventricular surface of the annulus such that (i) the distal portion is disposed perpendicular to the center portion, (ii) the center portion extends through the annulus, and (iii) the proximal portion is disposed in the right atrium;while the first anchor remains anchored inside the coronary sinus and the second anchor remains anchored to the site, reducing a distance between the first and second anchors by applying tension to a tensioning member coupled to (i) the proximal portion of the second anchor and (ii) the first anchor; andmaintaining the tension by locking a lock member to the tensioning member.
  • 2. The method according to claim 1, further comprising sliding the lock member along the tensioning member to the right atrium subsequently to anchoring the second anchor at the site.
  • 3. The method according to claim 1, further comprising, prior to anchoring the second anchor, forming an aperture at the site by puncturing the annulus with a wire, and wherein driving the distal portion through the annulus at the site comprises driving the distal portion through the aperture.
  • 4. The method according to claim 1, wherein: transluminally advancing the second anchor to the right atrium comprises transluminally advancing the second anchor to the right atrium while the second anchor is disposed within the second delivery device, with the distal portion disposed adjacent and parallel to the center portion, andanchoring the second anchor at the site comprises exposing the second anchor from the second delivery device such that the distal portion pivots automatically to become disposed perpendicular to the center portion.
  • 5. The method according to claim 1, wherein the tricuspid valve has an anterior leaflet, a septal leaflet, and a posterior leaflet, and wherein reducing the distance between the first and second anchors comprises reducing the distance between the first and second anchors such that the posterior leaflet becomes in effect eliminated.
  • 6. The method according to claim 1, wherein: advancing the first anchor comprises advancing the first anchor while the first anchor is collapsed around a deflated balloon of a balloon catheter of the first delivery device, andanchoring the first anchor comprises plastically expanding the first anchor within the coronary sinus by inflating the balloon.
  • 7. The method according to claim 1, wherein: the tensioning member is a second tensioning member, and is coupled to the first anchor via a first tensioning member,reducing the distance comprises reducing the distance by applying tension to the first and second tensioning members, andmaintaining the tension comprises maintaining the tension by locking the lock member to the first and second tensioning members.
  • 8. The method according to claim 7, wherein locking the lock member to the first and second tensioning members comprises locking the lock member to the first and second tensioning members such that the lock becomes implanted in the right atrium.
  • 9. The method according to claim 1, wherein anchoring the first anchor inside the coronary sinus comprises anchoring the first anchor inside the coronary sinus prior to transluminally advancing the second anchor to the right atrium.
  • 10. The method according to claim 9, wherein anchoring the first anchor inside the coronary sinus comprises anchoring the first anchor inside the coronary sinus with the tensioning member coupled to the first anchor, and wherein transluminally advancing the second anchor to the right atrium comprises sliding the second anchor over the tensioning member toward the right atrium.
  • 11. The method according to claim 10, wherein locking the lock member to the tensioning member comprises locking the lock member to the tensioning member such that the second anchor is disposed, on the tensioning member, between the lock member and the first anchor.
  • 12. The method according to claim 1, wherein: transluminally advancing the first anchor to the coronary sinus comprises transluminally advancing the first anchor to the coronary sinus while the first anchor is maintained in a collapsed state within the first delivery device, andanchoring the first anchor comprises radially expanding the first anchor within the coronary sinus.
  • 13. The method according to claim 12, wherein anchoring the first anchor comprises ejecting the first anchor from the first delivery device within the coronary sinus such that the first anchor self-expands within the coronary sinus.
  • 14. A method of treatment at a tricuspid valve of a heart of a subject, the tricuspid valve having an annulus and being disposed between a right atrium and a right ventricle of the heart, the heart having a coronary sinus, and the method comprising: transluminally advancing a first anchor to the coronary sinus and anchoring the first anchor inside the coronary sinus;transluminally advancing a second anchor to the right atrium while the second anchor is disposed within a delivery device, the second anchor including a proximal portion, a center portion, and a distal portion, andanchoring the second anchor at a site that is across the annulus from the coronary sinus by: driving the distal portion from the right atrium into the annulus at the site, andexposing the second anchor from the delivery device such that the distal portion pivots automatically to become disposed orthogonal to the center portion;while the first anchor remains anchored inside the coronary sinus and the second anchor remains anchored to the site, reducing a distance between the first and second anchors by applying tension to a tensioning member coupled to (i) the proximal portion of the second anchor and (ii) the first anchor; andmaintaining the tension by locking a lock member to the tensioning member.
  • 15. The method according to claim 14, further comprising sliding the lock member along the tensioning member to the right atrium subsequently to anchoring the second anchor at the site.
  • 16. The method according to claim 14, further comprising, prior to anchoring the second anchor, forming an aperture at the site by puncturing the annulus with a wire, and wherein driving the distal portion through the annulus at the site comprises driving the distal portion through the aperture.
  • 17. The method according to claim 14, wherein the tricuspid valve has an anterior leaflet, a septal leaflet, and a posterior leaflet, and wherein reducing the distance between the first and second anchors comprises reducing the distance between the first and second anchors such that the posterior leaflet becomes in effect eliminated.
  • 18. The method according to claim 14, wherein: advancing the first anchor comprises advancing the first anchor while the first anchor is collapsed around a deflated balloon of a balloon catheter, andanchoring the first anchor comprises plastically expanding the first anchor within the coronary sinus by inflating the balloon.
  • 19. The method according to claim 14, wherein: the tensioning member is a second tensioning member, and is coupled to the first anchor via a first tensioning member,reducing the distance comprises reducing the distance by applying tension to the first and second tensioning members, andmaintaining the tension comprises maintaining the tension by locking the lock member to the first and second tensioning members.
CROSS REFERENCE TO RELATED APPLICATION

The present application is a divisional of U.S. Ser. No. 15/393,809 to Sutherland et al., filed Dec. 29, 2016, which claims priority to U.S. patent application Ser. No. 62/272,871, filed Dec. 30, 2015. The foregoing applications are hereby incorporated by reference herein in their entirety.

US Referenced Citations (884)
Number Name Date Kind
3604488 Wishart et al. Sep 1971 A
3656185 Carpentier Apr 1972 A
3840018 Heifetz Oct 1974 A
3881366 Bradley et al. May 1975 A
3898701 La Russa Aug 1975 A
4042979 Angell Aug 1977 A
4118805 Reimels Oct 1978 A
4214349 Munch Jul 1980 A
4261342 Aranguren Duo Apr 1981 A
4290151 Massana Sep 1981 A
4434828 Trincia Mar 1984 A
4473928 Johnson Oct 1984 A
4602911 Ahmadi et al. Jul 1986 A
4625727 Leiboff Dec 1986 A
4712549 Peters et al. Dec 1987 A
4778468 Hunt et al. Oct 1988 A
4917698 Carpentier et al. Apr 1990 A
4935027 Yoon Jun 1990 A
4961738 Mackin Oct 1990 A
5042707 Taheri Aug 1991 A
5061277 Carpentier et al. Oct 1991 A
5064431 Gilbertson et al. Nov 1991 A
5104407 Lam et al. Apr 1992 A
5108420 Marks Apr 1992 A
5201880 Wright et al. Apr 1993 A
5258008 Wilk Nov 1993 A
5300034 Behnke et al. Apr 1994 A
5325845 Adair Jul 1994 A
5346498 Greelis et al. Sep 1994 A
5383852 Stevens-Wright Jan 1995 A
5449368 Kuzmak Sep 1995 A
5450860 O'Connor Sep 1995 A
5464404 Abela et al. Nov 1995 A
5474518 Farrer Velazquez Dec 1995 A
5477856 Lundquist Dec 1995 A
5593424 Northrup, III Jan 1997 A
5601572 Middleman et al. Feb 1997 A
5626609 Zvenyatsky et al. May 1997 A
5643317 Pavonik et al. Jul 1997 A
5669919 Sanders et al. Sep 1997 A
5676653 Taylor et al. Oct 1997 A
5683402 Cosgrove et al. Nov 1997 A
5702397 Goble et al. Dec 1997 A
5702398 Tarabishy Dec 1997 A
5709695 Northrup, III Jan 1998 A
5716370 Williamson, IV et al. Feb 1998 A
5716397 Myers Feb 1998 A
5728116 Rosenman Mar 1998 A
5730150 Peppel et al. Mar 1998 A
5749371 Zadini et al. May 1998 A
5752963 Allard et al. May 1998 A
5782844 Yoon et al. Jul 1998 A
5810882 Bolduc et al. Sep 1998 A
5824066 Gross Oct 1998 A
5830221 Stein et al. Nov 1998 A
5843120 Israel et al. Dec 1998 A
5855614 Stevens et al. Jan 1999 A
5876373 Giba et al. Mar 1999 A
5935098 Blaisdell et al. Aug 1999 A
5957953 DiPoto et al. Sep 1999 A
5961440 Schweich, Jr. et al. Oct 1999 A
5961539 Northrup et al. Oct 1999 A
5984959 Robertson et al. Nov 1999 A
5993459 Larsen et al. Nov 1999 A
6042554 Rosenman et al. Mar 2000 A
6045497 Schweich, Jr. et al. Apr 2000 A
6050936 Schweich, Jr. et al. Apr 2000 A
6059715 Schweich, Jr. et al. May 2000 A
6074341 Anderson et al. Jun 2000 A
6074401 Gardiner et al. Jun 2000 A
6074417 Peredo Jun 2000 A
6086582 Altman et al. Jul 2000 A
6102945 Campbell Aug 2000 A
6106550 Magovern et al. Aug 2000 A
6110200 Hinnenkamp Aug 2000 A
6132390 Cookston et al. Oct 2000 A
6143024 Campbell et al. Nov 2000 A
6159240 Sparer et al. Dec 2000 A
6165119 Schweich, Jr. et al. Dec 2000 A
6174332 Loch et al. Jan 2001 B1
6183411 Mortier et al. Feb 2001 B1
6187040 Wright Feb 2001 B1
6210347 Forsell Apr 2001 B1
6217610 Carpentier et al. Apr 2001 B1
6228032 Eaton et al. May 2001 B1
6231602 Carpentier et al. May 2001 B1
6251092 Qin et al. Jun 2001 B1
6296656 Bolduc et al. Oct 2001 B1
6315784 Djurovic Nov 2001 B1
6319281 Patel Nov 2001 B1
6328746 Gambale Dec 2001 B1
6332893 Mortier et al. Dec 2001 B1
6355030 Aldrich et al. Mar 2002 B1
6361559 Houser et al. Mar 2002 B1
6368348 Gabbay Apr 2002 B1
6402780 Williamson, IV et al. Jun 2002 B2
6406420 McCarthy et al. Jun 2002 B1
6406493 Tu et al. Jun 2002 B1
6419696 Ortiz et al. Jul 2002 B1
6451054 Stevens Sep 2002 B1
6458076 Pruitt Oct 2002 B1
6461336 Larre Oct 2002 B1
6461366 Seguin Oct 2002 B1
6470892 Forsell Oct 2002 B1
6503274 Howanec, Jr. et al. Jan 2003 B1
6524338 Gundry Feb 2003 B1
6527780 Wallace et al. Mar 2003 B1
6530952 Vesely Mar 2003 B2
6533772 Sherts et al. Mar 2003 B1
6537314 Langberg et al. Mar 2003 B2
6547801 Dargent et al. Apr 2003 B1
6554845 Fleenor et al. Apr 2003 B1
6564805 Garrison et al. May 2003 B2
6565603 Cox May 2003 B2
6569198 Wilson et al. May 2003 B1
6579297 Bicek et al. Jun 2003 B2
6589160 Schweich, Jr. et al. Jul 2003 B2
6592593 Parodi et al. Jul 2003 B1
6602288 Cosgrove et al. Aug 2003 B1
6602289 Colvin et al. Aug 2003 B1
6613078 Barone Sep 2003 B1
6613079 Wolinsky et al. Sep 2003 B1
6619291 Hlavka et al. Sep 2003 B2
6626899 Houser et al. Sep 2003 B2
6626917 Craig Sep 2003 B1
6626930 Allen et al. Sep 2003 B1
6629534 St. Goar et al. Oct 2003 B1
6629921 Schweich, Jr. et al. Oct 2003 B1
6651671 Donlon et al. Nov 2003 B1
6652556 VanTassel et al. Nov 2003 B1
6682558 Tu et al. Jan 2004 B2
6689125 Keith et al. Feb 2004 B1
6689164 Seguin Feb 2004 B1
6695866 Kuehn et al. Feb 2004 B1
6702826 Liddicoat et al. Mar 2004 B2
6702846 Mikus et al. Mar 2004 B2
6706065 Langberg et al. Mar 2004 B2
6709385 Forsell Mar 2004 B2
6709456 Langberg et al. Mar 2004 B2
6711444 Koblish Mar 2004 B2
6719786 Ryan et al. Apr 2004 B2
6723038 Schroeder et al. Apr 2004 B1
6726716 Marquez Apr 2004 B2
6726717 Alfieri et al. Apr 2004 B2
6730121 Ortiz et al. May 2004 B2
6749630 McCarthy et al. Jun 2004 B2
6752813 Goldfarb et al. Jun 2004 B2
6764310 Ichihashi et al. Jul 2004 B1
6764510 Vidlund et al. Jul 2004 B2
6764810 Ma et al. Jul 2004 B2
6770083 Seguin Aug 2004 B2
6786924 Ryan et al. Sep 2004 B2
6786925 Schoon et al. Sep 2004 B1
6790231 Liddicoat et al. Sep 2004 B2
6797001 Mathis et al. Sep 2004 B2
6797002 Spence et al. Sep 2004 B2
6802319 Stevens et al. Oct 2004 B2
6805710 Bolling et al. Oct 2004 B2
6805711 Quijano et al. Oct 2004 B2
6855126 Flinchbaugh Feb 2005 B2
6858039 McCarthy Feb 2005 B2
6884250 Monassevitch et al. Apr 2005 B2
6893459 Macoviak May 2005 B1
6908478 Alferness et al. Jun 2005 B2
6908482 McCarthy et al. Jun 2005 B2
6918917 Nguyen et al. Jul 2005 B1
6926730 Nguyen et al. Aug 2005 B1
6960217 Bolduc Nov 2005 B2
6964684 Ortiz et al. Nov 2005 B2
6964686 Gordon Nov 2005 B2
6976995 Mathis et al. Dec 2005 B2
6986775 Morales et al. Jan 2006 B2
6989028 Lashinski et al. Jan 2006 B2
6997951 Solem et al. Feb 2006 B2
7004176 Lau Feb 2006 B2
7007798 Happonen et al. Mar 2006 B2
7011669 Kimblad Mar 2006 B2
7011682 Lashinski et al. Mar 2006 B2
7018406 Seguin et al. Mar 2006 B2
7037334 Hlavka et al. May 2006 B1
7077850 Kortenbach Jul 2006 B2
7077862 Vidlund et al. Jul 2006 B2
7087064 Hyde Aug 2006 B1
7101395 Tremulis et al. Sep 2006 B2
7101396 Artof et al. Sep 2006 B2
7112207 Allen et al. Sep 2006 B2
7118595 Ryan et al. Oct 2006 B2
7125421 Tremulis et al. Oct 2006 B2
7150737 Purdy et al. Dec 2006 B2
7159593 McCarthy et al. Jan 2007 B2
7166127 Spence et al. Jan 2007 B2
7169187 Datta et al. Jan 2007 B2
7172625 Shu et al. Feb 2007 B2
7175660 Cartledge et al. Feb 2007 B2
7186262 Saadat Mar 2007 B2
7186264 Liddicoat et al. Mar 2007 B2
7189199 McCarthy et al. Mar 2007 B2
7192443 Solem et al. Mar 2007 B2
7220277 Arru et al. May 2007 B2
7226467 Lucatero et al. Jun 2007 B2
7226477 Cox Jun 2007 B2
7226647 Kasperchik et al. Jun 2007 B2
7229452 Kayan Jun 2007 B2
7238191 Bachmann Jul 2007 B2
7288097 Seguin Oct 2007 B2
7294148 McCarthy Nov 2007 B2
7311728 Solem et al. Dec 2007 B2
7311729 Mathis et al. Dec 2007 B2
7314485 Mathis Jan 2008 B2
7316710 Cheng et al. Jan 2008 B1
7329279 Haug et al. Feb 2008 B2
7329280 Bolling et al. Feb 2008 B2
7335213 Hyde et al. Feb 2008 B1
7361190 Shaoulian et al. Apr 2008 B2
7364588 Mathis et al. Apr 2008 B2
7377941 Rhee et al. May 2008 B2
7390329 Westra et al. Jun 2008 B2
7404824 Webler et al. Jul 2008 B1
7431692 Zollinger et al. Oct 2008 B2
7442207 Rafiee Oct 2008 B2
7452376 Lim et al. Nov 2008 B2
7455690 Cartledge et al. Nov 2008 B2
7485142 Milo Feb 2009 B2
7485143 Webler et al. Feb 2009 B2
7500989 Solem et al. Mar 2009 B2
7507252 Lashinski et al. Mar 2009 B2
7510575 Spenser et al. Mar 2009 B2
7510577 Moaddeb et al. Mar 2009 B2
7527647 Spence May 2009 B2
7530995 Quijano et al. May 2009 B2
7549983 Roue et al. Jun 2009 B2
7559936 Levine Jul 2009 B2
7562660 Saadat Jul 2009 B2
7563267 Goldfarb et al. Jul 2009 B2
7563273 Goldfarb et al. Jul 2009 B2
7569062 Kuehn et al. Aug 2009 B1
7585321 Cribier Sep 2009 B2
7588582 Starksen et al. Sep 2009 B2
7591826 Alferness et al. Sep 2009 B2
7604646 Goldfarb et al. Oct 2009 B2
7608091 Goldfarb et al. Oct 2009 B2
7608103 McCarthy Oct 2009 B2
7618449 Tremulis et al. Nov 2009 B2
7625403 Krivoruchko Dec 2009 B2
7632303 Stalker et al. Dec 2009 B1
7635329 Goldfarb et al. Dec 2009 B2
7635386 Gammie Dec 2009 B1
7655015 Goldfarb et al. Feb 2010 B2
7666204 Thornton et al. Feb 2010 B2
7682319 Martin et al. Mar 2010 B2
7682369 Seguin Mar 2010 B2
7686822 Shayani Mar 2010 B2
7699892 Rafiee et al. Apr 2010 B2
7704269 St. Goar et al. Apr 2010 B2
7704277 Zakay et al. Apr 2010 B2
7722666 Lafontaine May 2010 B2
7736388 Goldfarb et al. Jun 2010 B2
7748389 Salahieh et al. Jul 2010 B2
7753924 Starksen et al. Jul 2010 B2
7758632 Hojeibane et al. Jul 2010 B2
7780726 Seguin Aug 2010 B2
7871368 Zollinger et al. Jan 2011 B2
7871433 Lattouf Jan 2011 B2
7883475 Dupont et al. Feb 2011 B2
7883538 To et al. Feb 2011 B2
7892281 Seguin et al. Feb 2011 B2
7927370 Webler et al. Apr 2011 B2
7927371 Navia et al. Apr 2011 B2
7942927 Kaye et al. May 2011 B2
7947056 Griego et al. May 2011 B2
7955315 Feinberg et al. Jun 2011 B2
7955377 Melsheimer Jun 2011 B2
7981152 Webler et al. Jul 2011 B1
7992567 Hirotsuka et al. Aug 2011 B2
7993368 Gambale et al. Aug 2011 B2
7993397 Lashinski et al. Aug 2011 B2
8012201 Lashinski et al. Sep 2011 B2
8034103 Burriesci et al. Oct 2011 B2
8052592 Goldfarb et al. Nov 2011 B2
8057493 Goldfarb et al. Nov 2011 B2
8062355 Figulla et al. Nov 2011 B2
8070804 Hyde et al. Dec 2011 B2
8070805 Vidlund et al. Dec 2011 B2
8075616 Solem et al. Dec 2011 B2
8100964 Spence Jan 2012 B2
8123801 Milo Feb 2012 B2
8142493 Spence et al. Mar 2012 B2
8142495 Hasenkam et al. Mar 2012 B2
8142496 Berreklouw Mar 2012 B2
8147542 Maisano et al. Apr 2012 B2
8152844 Rao et al. Apr 2012 B2
8163013 Machold et al. Apr 2012 B2
8187299 Goldfarb et al. May 2012 B2
8187324 Webler et al. May 2012 B2
8202315 Hlavka et al. Jun 2012 B2
8206439 Gomez Duran Jun 2012 B2
8216302 Wilson et al. Jul 2012 B2
8231671 Kim Jul 2012 B2
8262725 Subramanian Sep 2012 B2
8265758 Policker et al. Sep 2012 B2
8277502 Miller et al. Oct 2012 B2
8287584 Salahieh et al. Oct 2012 B2
8287591 Keidar et al. Oct 2012 B2
8292884 Levine et al. Oct 2012 B2
8303608 Goldfarb et al. Nov 2012 B2
8323334 Deem et al. Dec 2012 B2
8328868 Paul et al. Dec 2012 B2
8333777 Schaller et al. Dec 2012 B2
8343173 Starksen et al. Jan 2013 B2
8343174 Goldfarb et al. Jan 2013 B2
8343213 Salahieh et al. Jan 2013 B2
8349002 Milo Jan 2013 B2
8353956 Miller et al. Jan 2013 B2
8357195 Kuehn Jan 2013 B2
8382829 Call et al. Feb 2013 B1
8388680 Starksen et al. Mar 2013 B2
8393517 Milo Mar 2013 B2
8419825 Burgler et al. Apr 2013 B2
8430926 Kirson Apr 2013 B2
8449573 Chu May 2013 B2
8449599 Chau et al. May 2013 B2
8454686 Alkhatib Jun 2013 B2
8460370 Zakay Jun 2013 B2
8460371 Hlavka et al. Jun 2013 B2
8475491 Milo Jul 2013 B2
8475525 Maisano et al. Jul 2013 B2
8480732 Subramanian Jul 2013 B2
8518107 Tsukashima et al. Aug 2013 B2
8523940 Richardson et al. Sep 2013 B2
8551161 Dolan Oct 2013 B2
8585755 Chau et al. Nov 2013 B2
8591576 Hasenkam et al. Nov 2013 B2
8608797 Gross et al. Dec 2013 B2
8628569 Benichou et al. Jan 2014 B2
8628571 Hacohen et al. Jan 2014 B1
8641727 Starksen et al. Feb 2014 B2
8652202 Alon et al. Feb 2014 B2
8652203 Quadri et al. Feb 2014 B2
8679174 Ottma et al. Mar 2014 B2
8685086 Navia et al. Apr 2014 B2
8728097 Sugimoto et al. May 2014 B1
8728155 Montorfano et al. May 2014 B2
8734467 Miller et al. May 2014 B2
8734699 Heideman et al. May 2014 B2
8740920 Goldfarb et al. Jun 2014 B2
8747463 Fogarty et al. Jun 2014 B2
8778021 Cartledge Jul 2014 B2
8784481 Alkhatib et al. Jul 2014 B2
8790367 Nguyen et al. Jul 2014 B2
8790394 Miller et al. Jul 2014 B2
8795298 Hernlund et al. Aug 2014 B2
8795355 Alkhatib Aug 2014 B2
8795356 Quadri et al. Aug 2014 B2
8795357 Yohanan et al. Aug 2014 B2
8808366 Braido et al. Aug 2014 B2
8808368 Maisano et al. Aug 2014 B2
8845717 Khairkhahan et al. Sep 2014 B2
8845723 Spence et al. Sep 2014 B2
8852261 White Oct 2014 B2
8852272 Gross et al. Oct 2014 B2
8858623 Miller et al. Oct 2014 B2
8864822 Spence et al. Oct 2014 B2
8870948 Erzberger et al. Oct 2014 B1
8870949 Rowe Oct 2014 B2
8888843 Khairkhahan et al. Nov 2014 B2
8889861 Skead et al. Nov 2014 B2
8894702 Quadri et al. Nov 2014 B2
8911461 Traynor et al. Dec 2014 B2
8911494 Hammer et al. Dec 2014 B2
8926696 Cabiri et al. Jan 2015 B2
8926697 Gross et al. Jan 2015 B2
8932343 Alkhatib et al. Jan 2015 B2
8932348 Solem et al. Jan 2015 B2
8940044 Hammer et al. Jan 2015 B2
8945211 Sugimoto Feb 2015 B2
8951285 Sugimoto et al. Feb 2015 B2
8951286 Sugimoto et al. Feb 2015 B2
8961595 Alkhatib Feb 2015 B2
8961602 Kovach et al. Feb 2015 B2
8979922 Jayasinghe et al. Mar 2015 B2
8992604 Gross et al. Mar 2015 B2
9005273 Salahieh et al. Apr 2015 B2
9011520 Miller et al. Apr 2015 B2
9011530 Reich et al. Apr 2015 B2
9023100 Quadri et al. May 2015 B2
9072603 Tuval et al. Jul 2015 B2
9107749 Bobo et al. Aug 2015 B2
9119719 Zipory et al. Sep 2015 B2
9125632 Loulmet et al. Sep 2015 B2
9125742 Yoganathan et al. Sep 2015 B2
9138316 Bielefeld Sep 2015 B2
9173646 Fabro Nov 2015 B2
9180005 Lashinski et al. Nov 2015 B1
9180007 Reich et al. Nov 2015 B2
9192472 Gross et al. Nov 2015 B2
9198756 Aklog et al. Dec 2015 B2
9226825 Starksen et al. Jan 2016 B2
9265608 Miller et al. Feb 2016 B2
9326857 Cartledge et al. May 2016 B2
9414921 Miller et al. Aug 2016 B2
9427316 Schweich, Jr. et al. Aug 2016 B2
9474606 Zipory et al. Oct 2016 B2
9526613 Gross et al. Dec 2016 B2
9561104 Miller et al. Feb 2017 B2
9579090 Simms et al. Feb 2017 B1
9693865 Gilmore et al. Jul 2017 B2
9724084 Groothuis et al. Aug 2017 B2
9730793 Reich et al. Aug 2017 B2
9788941 Hacohen Oct 2017 B2
9801720 Gilmore et al. Oct 2017 B2
9907547 Gilmore et al. Mar 2018 B2
10368852 Gerhardt et al. Aug 2019 B2
20010021874 Carpentier et al. Sep 2001 A1
20020022862 Grafton et al. Feb 2002 A1
20020082525 Oslund et al. Jun 2002 A1
20020087048 Brock et al. Jul 2002 A1
20020103532 Langberg et al. Aug 2002 A1
20020120292 Morgan Aug 2002 A1
20020151916 Muramatsu et al. Oct 2002 A1
20020151970 Garrison et al. Oct 2002 A1
20020169358 Mortier et al. Nov 2002 A1
20020177904 Huxel et al. Nov 2002 A1
20020188301 Dallara et al. Dec 2002 A1
20020188350 Arru et al. Dec 2002 A1
20020198586 Inoue Dec 2002 A1
20030050693 Quijano et al. Mar 2003 A1
20030078465 Pai et al. Apr 2003 A1
20030078653 Vesely et al. Apr 2003 A1
20030083538 Adams et al. May 2003 A1
20030093148 Bolling et al. May 2003 A1
20030105519 Fasol et al. Jun 2003 A1
20030114901 Loeb et al. Jun 2003 A1
20030120340 Liska et al. Jun 2003 A1
20030144657 Bowe et al. Jul 2003 A1
20030171760 Gambale Sep 2003 A1
20030199974 Lee et al. Oct 2003 A1
20030204193 Gabriel et al. Oct 2003 A1
20030204195 Keane et al. Oct 2003 A1
20030229350 Kay Dec 2003 A1
20030229395 Cox Dec 2003 A1
20040002735 Lizardi et al. Jan 2004 A1
20040010287 Bonutti Jan 2004 A1
20040019359 Worley et al. Jan 2004 A1
20040019377 Taylor et al. Jan 2004 A1
20040024451 Johnson et al. Feb 2004 A1
20040039442 St. Goar et al. Feb 2004 A1
20040044350 Martin et al. Mar 2004 A1
20040049211 Tremulis et al. Mar 2004 A1
20040059413 Argento Mar 2004 A1
20040068273 Fariss et al. Apr 2004 A1
20040111095 Gordon et al. Jun 2004 A1
20040122514 Fogarty et al. Jun 2004 A1
20040127982 Machold et al. Jul 2004 A1
20040133274 Webler et al. Jul 2004 A1
20040133374 Kattan Jul 2004 A1
20040138744 Lashinski et al. Jul 2004 A1
20040138745 Macoviak et al. Jul 2004 A1
20040148019 Vidlund et al. Jul 2004 A1
20040148020 Vidlund et al. Jul 2004 A1
20040148021 Cartledge et al. Jul 2004 A1
20040176788 Opolski Sep 2004 A1
20040181287 Gellman Sep 2004 A1
20040186566 Hindrichs et al. Sep 2004 A1
20040193191 Starksen et al. Sep 2004 A1
20040243227 Starksen et al. Dec 2004 A1
20040260317 Bloom et al. Dec 2004 A1
20040260344 Lyons et al. Dec 2004 A1
20040260393 Rahdert et al. Dec 2004 A1
20040260394 Douk et al. Dec 2004 A1
20040267358 Reitan Dec 2004 A1
20050004668 Aklog et al. Jan 2005 A1
20050010287 Macoviak et al. Jan 2005 A1
20050010787 Tarbouriech Jan 2005 A1
20050016560 Voughlohn Jan 2005 A1
20050049692 Numamoto et al. Mar 2005 A1
20050055038 Kelleher et al. Mar 2005 A1
20050055087 Starksen Mar 2005 A1
20050060030 Lashinski et al. Mar 2005 A1
20050065601 Lee et al. Mar 2005 A1
20050070999 Spence Mar 2005 A1
20050075727 Wheatley Apr 2005 A1
20050090827 Gedebou Apr 2005 A1
20050090834 Chiang et al. Apr 2005 A1
20050096740 Langberg et al. May 2005 A1
20050107871 Realyvasquez et al. May 2005 A1
20050119734 Spence et al. Jun 2005 A1
20050125002 Baran et al. Jun 2005 A1
20050125011 Spence et al. Jun 2005 A1
20050131533 Alfieri et al. Jun 2005 A1
20050137686 Salahieh et al. Jun 2005 A1
20050137688 Salahieh et al. Jun 2005 A1
20050137695 Salahieh et al. Jun 2005 A1
20050159728 Armour et al. Jul 2005 A1
20050159810 Filsoufi Jul 2005 A1
20050171601 Cosgrove et al. Aug 2005 A1
20050177180 Kaganov et al. Aug 2005 A1
20050177228 Solem et al. Aug 2005 A1
20050187568 Klenk et al. Aug 2005 A1
20050192596 Jugenheimer et al. Sep 2005 A1
20050203549 Realyvasquez Sep 2005 A1
20050203606 VanCamp Sep 2005 A1
20050216039 Lederman Sep 2005 A1
20050216079 MaCoviak Sep 2005 A1
20050222665 Aranyi Oct 2005 A1
20050234481 Waller Oct 2005 A1
20050240199 Martinek et al. Oct 2005 A1
20050256532 Nayak et al. Nov 2005 A1
20050267478 Corradi et al. Dec 2005 A1
20050273138 To et al. Dec 2005 A1
20050288778 Shaoulian et al. Dec 2005 A1
20060004442 Spenser et al. Jan 2006 A1
20060004443 Liddicoat et al. Jan 2006 A1
20060020326 Bolduc et al. Jan 2006 A9
20060020327 Lashinski et al. Jan 2006 A1
20060020333 Lashinski et al. Jan 2006 A1
20060020336 Liddicoat Jan 2006 A1
20060025787 Morales et al. Feb 2006 A1
20060025858 Alameddine Feb 2006 A1
20060030885 Hyde Feb 2006 A1
20060041319 Taylor et al. Feb 2006 A1
20060069429 Spence et al. Mar 2006 A1
20060074486 Liddicoat et al. Apr 2006 A1
20060085012 Dolan Apr 2006 A1
20060095009 Lampropoulos et al. May 2006 A1
20060106423 Weisel et al. May 2006 A1
20060116757 Lashinski et al. Jun 2006 A1
20060122633 To et al. Jun 2006 A1
20060129166 Lavelle Jun 2006 A1
20060142694 Bednarek et al. Jun 2006 A1
20060149280 Harvie et al. Jul 2006 A1
20060149368 Spence Jul 2006 A1
20060161265 Levine et al. Jul 2006 A1
20060184240 Jimenez et al. Aug 2006 A1
20060184242 Lichtenstein Aug 2006 A1
20060195134 Crittenden Aug 2006 A1
20060206203 Yang et al. Sep 2006 A1
20060241622 Zergiebel Oct 2006 A1
20060241656 Starksen et al. Oct 2006 A1
20060241748 Lee et al. Oct 2006 A1
20060247763 Slater Nov 2006 A1
20060259135 Navia et al. Nov 2006 A1
20060271175 Woolfson et al. Nov 2006 A1
20060276871 Lamson et al. Dec 2006 A1
20060282161 Huynh et al. Dec 2006 A1
20060287661 Bolduc et al. Dec 2006 A1
20060287716 Banbury et al. Dec 2006 A1
20070001627 Lin et al. Jan 2007 A1
20070010800 Weitzner et al. Jan 2007 A1
20070016287 Cartledge et al. Jan 2007 A1
20070016288 Gurskis et al. Jan 2007 A1
20070021781 Jervis et al. Jan 2007 A1
20070027533 Douk Feb 2007 A1
20070027536 Mihaljevic et al. Feb 2007 A1
20070032823 Tegg Feb 2007 A1
20070038221 Fine et al. Feb 2007 A1
20070038293 St.Goar et al. Feb 2007 A1
20070038296 Navia et al. Feb 2007 A1
20070039425 Wang Feb 2007 A1
20070049942 Hindrichs et al. Mar 2007 A1
20070049970 Belef et al. Mar 2007 A1
20070051377 Douk et al. Mar 2007 A1
20070055206 To et al. Mar 2007 A1
20070061010 Hauser et al. Mar 2007 A1
20070066863 Rafiee et al. Mar 2007 A1
20070078297 Rafiee et al. Apr 2007 A1
20070080188 Spence et al. Apr 2007 A1
20070083168 Whiting et al. Apr 2007 A1
20070083235 Jervis et al. Apr 2007 A1
20070100427 Perouse May 2007 A1
20070106328 Wardle et al. May 2007 A1
20070112359 Kimura et al. May 2007 A1
20070112422 Dehdashtian May 2007 A1
20070112425 Schaller et al. May 2007 A1
20070118151 Davidson May 2007 A1
20070118154 Crabtree May 2007 A1
20070118213 Loulmet May 2007 A1
20070118215 Moaddeb May 2007 A1
20070142907 Moaddeb et al. Jun 2007 A1
20070162111 Fukamachi et al. Jul 2007 A1
20070173931 Tremulis et al. Jul 2007 A1
20070198082 Kapadia et al. Aug 2007 A1
20070219558 Deutsch Sep 2007 A1
20070239208 Crawford Oct 2007 A1
20070244554 Rafiee et al. Oct 2007 A1
20070244556 Rafiee et al. Oct 2007 A1
20070255397 Ryan et al. Nov 2007 A1
20070255400 Parravicini et al. Nov 2007 A1
20070270755 Von Oepen et al. Nov 2007 A1
20070276437 Call et al. Nov 2007 A1
20070282375 Hindrichs et al. Dec 2007 A1
20070282429 Hauser et al. Dec 2007 A1
20070295172 Swartz Dec 2007 A1
20070299424 Cumming et al. Dec 2007 A1
20080004697 Lichtenstein et al. Jan 2008 A1
20080027483 Cartledge et al. Jan 2008 A1
20080027555 Hawkins Jan 2008 A1
20080035160 Woodson et al. Feb 2008 A1
20080039935 Buch et al. Feb 2008 A1
20080051703 Thornton et al. Feb 2008 A1
20080058595 Snoke et al. Mar 2008 A1
20080065011 Marchand et al. Mar 2008 A1
20080065204 Macoviak et al. Mar 2008 A1
20080071366 Tuval et al. Mar 2008 A1
20080086138 Stone et al. Apr 2008 A1
20080086203 Roberts Apr 2008 A1
20080091169 Heideman et al. Apr 2008 A1
20080091257 Andreas et al. Apr 2008 A1
20080097483 Ortiz et al. Apr 2008 A1
20080097523 Bolduc et al. Apr 2008 A1
20080103572 Gerber May 2008 A1
20080140116 Bonutti Jun 2008 A1
20080167713 Bolling Jul 2008 A1
20080167714 St. Goar et al. Jul 2008 A1
20080177380 Starksen et al. Jul 2008 A1
20080195126 Solem Aug 2008 A1
20080195200 Vidlund et al. Aug 2008 A1
20080208265 Frazier et al. Aug 2008 A1
20080221672 Lamphere et al. Sep 2008 A1
20080228030 Godin Sep 2008 A1
20080228223 Alkhatib Sep 2008 A1
20080234729 Page et al. Sep 2008 A1
20080262480 Stahler et al. Oct 2008 A1
20080262609 Gross et al. Oct 2008 A1
20080275300 Rothe et al. Nov 2008 A1
20080275469 Fanton et al. Nov 2008 A1
20080275551 Alfieri Nov 2008 A1
20080281353 Aranyi et al. Nov 2008 A1
20080281411 Berreklouw Nov 2008 A1
20080287862 Weitzner et al. Nov 2008 A1
20080288044 Osborne Nov 2008 A1
20080288062 Andrieu et al. Nov 2008 A1
20080294251 Annest et al. Nov 2008 A1
20080300537 Bowman Dec 2008 A1
20080300629 Surti Dec 2008 A1
20080312506 Spivey et al. Dec 2008 A1
20090024110 Heideman et al. Jan 2009 A1
20090028670 Garcia et al. Jan 2009 A1
20090043381 Macoviak et al. Feb 2009 A1
20090054723 Khairkhahan et al. Feb 2009 A1
20090054969 Salahieh et al. Feb 2009 A1
20090062866 Jackson Mar 2009 A1
20090076586 Hauser et al. Mar 2009 A1
20090076600 Quinn Mar 2009 A1
20090082797 Fung Mar 2009 A1
20090088837 Gillinov et al. Apr 2009 A1
20090093670 Annest Apr 2009 A1
20090093877 Keidar et al. Apr 2009 A1
20090099650 Bolduc et al. Apr 2009 A1
20090105816 Olsen et al. Apr 2009 A1
20090125102 Cartledge et al. May 2009 A1
20090166913 Guo et al. Jul 2009 A1
20090171439 Nissl Jul 2009 A1
20090177266 Powell et al. Jul 2009 A1
20090177274 Scorsin et al. Jul 2009 A1
20090248148 Shaolian et al. Oct 2009 A1
20090254103 Deutsch Oct 2009 A1
20090264994 Saadat Oct 2009 A1
20090287231 Brooks et al. Nov 2009 A1
20090287304 Dahlgren et al. Nov 2009 A1
20090299409 Coe et al. Dec 2009 A1
20090326648 Machold et al. Dec 2009 A1
20100001038 Levin et al. Jan 2010 A1
20100010538 Juravic et al. Jan 2010 A1
20100023118 Medlock et al. Jan 2010 A1
20100030014 Ferrazzi Feb 2010 A1
20100030328 Seguin et al. Feb 2010 A1
20100042147 Janovsky et al. Feb 2010 A1
20100049213 Serina et al. Feb 2010 A1
20100063542 van der Burg et al. Mar 2010 A1
20100063550 Felix et al. Mar 2010 A1
20100076499 McNamara et al. Mar 2010 A1
20100094248 Nguyen et al. Apr 2010 A1
20100094314 Hernlund et al. Apr 2010 A1
20100106141 Osypka et al. Apr 2010 A1
20100114180 Rock et al. May 2010 A1
20100121349 Meier et al. May 2010 A1
20100121435 Subramanian et al. May 2010 A1
20100121437 Subramanian et al. May 2010 A1
20100130989 Bourque et al. May 2010 A1
20100130992 Machold et al. May 2010 A1
20100152845 Bloom et al. Jun 2010 A1
20100161043 Maisano et al. Jun 2010 A1
20100168845 Wright Jul 2010 A1
20100174358 Rabkin et al. Jul 2010 A1
20100179574 Longoria et al. Jul 2010 A1
20100217184 Koblish et al. Aug 2010 A1
20100217382 Chau et al. Aug 2010 A1
20100234935 Bashiri et al. Sep 2010 A1
20100249497 Peine et al. Sep 2010 A1
20100249908 Chau et al. Sep 2010 A1
20100249915 Zhang Sep 2010 A1
20100249920 Bolling et al. Sep 2010 A1
20100262232 Annest Oct 2010 A1
20100262233 He Oct 2010 A1
20100286628 Gross Nov 2010 A1
20100298929 Thornton et al. Nov 2010 A1
20100305475 Hinchliffe et al. Dec 2010 A1
20100324598 Anderson Dec 2010 A1
20110004210 Johnson et al. Jan 2011 A1
20110004298 Lee et al. Jan 2011 A1
20110009956 Cartledge et al. Jan 2011 A1
20110011917 Loulmet Jan 2011 A1
20110026208 Utsuro et al. Feb 2011 A1
20110029066 Gilad et al. Feb 2011 A1
20110035000 Nieminen et al. Feb 2011 A1
20110066231 Cartledge et al. Mar 2011 A1
20110067770 Pederson et al. Mar 2011 A1
20110071626 Wright et al. Mar 2011 A1
20110082538 Dahlgren et al. Apr 2011 A1
20110087146 Ryan et al. Apr 2011 A1
20110093002 Rucker et al. Apr 2011 A1
20110118832 Punjabi May 2011 A1
20110137410 Hacohen Jun 2011 A1
20110144576 Rothe et al. Jun 2011 A1
20110144703 Krause et al. Jun 2011 A1
20110202130 Cartledge et al. Aug 2011 A1
20110208283 Rust Aug 2011 A1
20110230941 Markus Sep 2011 A1
20110230961 Langer et al. Sep 2011 A1
20110238088 Bolduc et al. Sep 2011 A1
20110257433 Walker Oct 2011 A1
20110257633 Cartledge et al. Oct 2011 A1
20110264208 Duffy et al. Oct 2011 A1
20110276062 Bolduc Nov 2011 A1
20110288435 Christy et al. Nov 2011 A1
20110301498 Maenhout et al. Dec 2011 A1
20120053628 Sojka et al. Mar 2012 A1
20120065464 Ellis et al. Mar 2012 A1
20120078355 Zipory et al. Mar 2012 A1
20120078359 Li et al. Mar 2012 A1
20120089022 House et al. Apr 2012 A1
20120089125 Scheibe et al. Apr 2012 A1
20120095552 Spence et al. Apr 2012 A1
20120109155 Robinson et al. May 2012 A1
20120150290 Gabbay Jun 2012 A1
20120158021 Morrill Jun 2012 A1
20120158023 Mitelberg et al. Jun 2012 A1
20120179086 Shank et al. Jul 2012 A1
20120191182 Hauser et al. Jul 2012 A1
20120226349 Tuval et al. Sep 2012 A1
20120239142 Liu et al. Sep 2012 A1
20120245604 Tegzes Sep 2012 A1
20120271198 Whittaker et al. Oct 2012 A1
20120296349 Smith et al. Nov 2012 A1
20120296417 Hill et al. Nov 2012 A1
20120310330 Buchbinder et al. Dec 2012 A1
20120323313 Seguin Dec 2012 A1
20130018459 Maisano Jan 2013 A1
20130030522 Rowe et al. Jan 2013 A1
20130046373 Cartledge et al. Feb 2013 A1
20130053884 Roorda Feb 2013 A1
20130079873 Migliazza et al. Mar 2013 A1
20130085529 Housman Apr 2013 A1
20130090724 Subramanian et al. Apr 2013 A1
20130096673 Hill et al. Apr 2013 A1
20130103055 Schaller et al. Apr 2013 A1
20130116776 Gross et al. May 2013 A1
20130123910 Cartledge et al. May 2013 A1
20130131791 Hlavka et al. May 2013 A1
20130166017 Cartledge et al. Jun 2013 A1
20130190863 Call et al. Jul 2013 A1
20130204361 Adams et al. Aug 2013 A1
20130226289 Shaolian et al. Aug 2013 A1
20130226290 Yellin et al. Aug 2013 A1
20130231701 Voss et al. Sep 2013 A1
20130268069 Zakai et al. Oct 2013 A1
20130282059 Ketai et al. Oct 2013 A1
20130289718 Tsukashima et al. Oct 2013 A1
20130297013 Klima et al. Nov 2013 A1
20130304093 Serina et al. Nov 2013 A1
20130331930 Rowe et al. Dec 2013 A1
20140067054 Chau et al. Mar 2014 A1
20140081394 Keranen et al. Mar 2014 A1
20140088368 Park Mar 2014 A1
20140088646 Wales et al. Mar 2014 A1
20140094826 Sutherland et al. Apr 2014 A1
20140094903 Miller et al. Apr 2014 A1
20140094906 Spence et al. Apr 2014 A1
20140114390 Tobis et al. Apr 2014 A1
20140135799 Henderson May 2014 A1
20140142619 Serina et al. May 2014 A1
20140142695 Gross et al. May 2014 A1
20140148849 Serina et al. May 2014 A1
20140155783 Starksen et al. Jun 2014 A1
20140163670 Alon et al. Jun 2014 A1
20140163690 White Jun 2014 A1
20140188108 Goodine et al. Jul 2014 A1
20140188140 Meier et al. Jul 2014 A1
20140188215 Hlavka et al. Jul 2014 A1
20140194976 Starksen et al. Jul 2014 A1
20140207231 Hacohen et al. Jul 2014 A1
20140243859 Robinson Aug 2014 A1
20140243894 Groothuis et al. Aug 2014 A1
20140243963 Sheps et al. Aug 2014 A1
20140251042 Asselin et al. Sep 2014 A1
20140275757 Goodwin et al. Sep 2014 A1
20140276648 Hammer et al. Sep 2014 A1
20140296962 Cartledge et al. Oct 2014 A1
20140303649 Nguyen et al. Oct 2014 A1
20140303720 Sugimoto et al. Oct 2014 A1
20140309661 Sheps et al. Oct 2014 A1
20140309730 Alon et al. Oct 2014 A1
20140343668 Zipory et al. Nov 2014 A1
20140350657 Headley Nov 2014 A1
20140350660 Cocks et al. Nov 2014 A1
20140379006 Sutherland et al. Dec 2014 A1
20150018940 Quill Jan 2015 A1
20150051697 Spence et al. Feb 2015 A1
20150081014 Gross et al. Mar 2015 A1
20150094800 Chawla Apr 2015 A1
20150100116 Mohl et al. Apr 2015 A1
20150112432 Reich et al. Apr 2015 A1
20150119936 Gilmore Apr 2015 A1
20150127097 Neumann et al. May 2015 A1
20150133997 Deitch et al. May 2015 A1
20150182336 Zipory et al. Jul 2015 A1
20150230919 Chau et al. Aug 2015 A1
20150272586 Herman et al. Oct 2015 A1
20150272734 Sheps et al. Oct 2015 A1
20150282931 Brunnett et al. Oct 2015 A1
20150351910 Gilmore et al. Dec 2015 A1
20160008132 Cabiri et al. Jan 2016 A1
20160029920 Kronstrom et al. Feb 2016 A1
20160058557 Reich et al. Mar 2016 A1
20160113767 Miller et al. Apr 2016 A1
20160120642 Shaolian et al. May 2016 A1
20160120645 Alon May 2016 A1
20160158008 Miller et al. Jun 2016 A1
20160242762 Gilmore et al. Aug 2016 A1
20160256149 Sampson et al. Sep 2016 A1
20160262755 Zipory et al. Sep 2016 A1
20160302917 Schewel Oct 2016 A1
20160317302 Madjarov et al. Nov 2016 A1
20160361058 Bolduc et al. Dec 2016 A1
20160361168 Gross et al. Dec 2016 A1
20160361169 Gross et al. Dec 2016 A1
20170000609 Gross et al. Jan 2017 A1
20170042670 Shaolian et al. Feb 2017 A1
20170100119 Baird et al. Apr 2017 A1
20170224489 Starksen et al. Aug 2017 A1
20170245993 Gross et al. Aug 2017 A1
20180008409 Kutzik et al. Jan 2018 A1
20180049875 Iflah et al. Feb 2018 A1
20180140420 Hayoz et al. May 2018 A1
20180168803 Pesce et al. Jun 2018 A1
20180228608 Sheps et al. Aug 2018 A1
20180256334 Sheps et al. Sep 2018 A1
20180289480 D'ambra et al. Oct 2018 A1
20180318080 Quill et al. Nov 2018 A1
20180318083 Bolling et al. Nov 2018 A1
20190029498 Mankowski et al. Jan 2019 A1
20190038411 Alon Feb 2019 A1
20190111239 Bolduc et al. Apr 2019 A1
20190117400 Medema et al. Apr 2019 A1
20190125325 Sheps et al. May 2019 A1
20190151093 Keidar et al. May 2019 A1
20190159898 Kutzik et al. May 2019 A1
20190175344 Khairkhahan Jun 2019 A1
20190175345 Schaffner et al. Jun 2019 A1
20190175346 Schaffner et al. Jun 2019 A1
20190183648 Trapp et al. Jun 2019 A1
20190240023 Spence et al. Aug 2019 A1
20190290260 Caffes et al. Sep 2019 A1
20190290431 Genovese et al. Sep 2019 A1
20190321049 Herman et al. Oct 2019 A1
20190343633 Garvin et al. Nov 2019 A1
20200015971 Brauon et al. Jan 2020 A1
20200289267 Peleg et al. Sep 2020 A1
20200337840 Reich Oct 2020 A1
20210015475 Lau Jan 2021 A1
20210059820 Clark et al. Mar 2021 A1
20210085461 Neumark et al. Mar 2021 A1
20210093453 Peleg et al. Apr 2021 A1
20210145584 Kasher et al. May 2021 A1
20220000464 Schaller et al. Jan 2022 A1
20220071620 Brauon et al. Mar 2022 A1
20220096232 Skaro et al. Mar 2022 A1
20220142779 Sharon May 2022 A1
20220176076 Keidar Jun 2022 A1
20220233316 Sheps et al. Jul 2022 A1
20220273436 Aviv et al. Sep 2022 A1
20220313438 Chappel-Ram Oct 2022 A1
20220323221 Sharon et al. Oct 2022 A1
20230016867 Tennenbaum Jan 2023 A1
Foreign Referenced Citations (31)
Number Date Country
113331995 Sep 2021 CN
1034753 Sep 2000 EP
3531975 Sep 2019 EP
9205093 Apr 1992 WO
9846149 Oct 1998 WO
02085250 Feb 2003 WO
03047467 Jun 2003 WO
2007098512 Sep 2007 WO
2010000454 Jan 2010 WO
2012176195 Mar 2013 WO
2014064964 May 2014 WO
2015063580 May 2015 WO
2019145941 Aug 2019 WO
2019145947 Aug 2019 WO
2019182645 Sep 2019 WO
2019224814 Nov 2019 WO
2020240282 Dec 2020 WO
2021014440 Jan 2021 WO
2021038559 Mar 2021 WO
2021038560 Mar 2021 WO
2022064401 Mar 2022 WO
2022090907 May 2022 WO
2022101817 May 2022 WO
2022153131 Jul 2022 WO
2022157592 Jul 2022 WO
2022172108 Aug 2022 WO
2022172149 Aug 2022 WO
2022200972 Sep 2022 WO
2022224071 Oct 2022 WO
2022229815 Nov 2022 WO
2022250983 Dec 2022 WO
Non-Patent Literature Citations (28)
Entry
Agarwal et al. International Cardiology Perspective Functional Tricuspid Regurgitation, Circ Cardiovasc Interv 2009:2;2;565-573 (2009).
Ahmadi, A., G. Spillner, and Th Johannesson. “Hemodynamic changes following experimental production and correction of acute mitral regurgitation with an adjustable ring prosthesis.” The Thoracic and cardiovascular surgeon36.06 (1988): 313-319.
Ahmadi, Ali et al. “Percutaneously adjustable pulmonary artery band.” The Annals of thoracic surgery 60 (1995): S520-S522.
Alfieri et al.“Novel Suture Device for Beating-Heart Mitral Leaflet Approximation”, Ann Thorac Surg. 2002, 74:1488-1493.
Alfieri et al., “An effective technique to correct anterior mitral leaflet prolapse,” J Card 14(6):468-470 (1999).
Alfieri et al., “The double orifice technique in mitral valve repair: a simple solution for complex problems,” Journal of Thoracic Cardiovascular Surgery 122:674-681 (2001).
Alfieri, “The edge-to-edge repair of the mitral valve,” [Abstract] 6th Annual NewEra Cardiac Care: Innovation & Technology, Heart Surgery Forum pp. 103. (2000).
Amplatzer Cardiac Plug brochure (English pages), AGA Medical Corporation (Plymouth, MN) (copyright 2008-2010, downloaded Jan. 11, 2011).
Amplatzer® Cribriform Occluder. A patient guide to Percutaneous, Transcatheter, Atrial Septal Defect Closuer, AGA Medical Corporation, Apr. 2008.
Amplatzer® Septal Occluder. A patient guide to the Non-Surgical Closuer of the Atrial Septal Defect Using the Amplatzer Septal Occluder System, AGA Medical Corporation, Apr. 2008.
Assad, Renato S. “Adjustable Pulmonary Artery Banding.” (2014).
Brennan, Jennifer, 510(k) Summary of safety and effectiveness, Jan. 2008.
Daebritz, S. et al. “Experience with an adjustable pulmonary artery banding device in two cases: initial success—midterm failure.” The Thoracic and cardiovascular surgeon 47.01 (1999): 51-52.
Dang NC et al. “Simplified Placement of Multiple Artificial Mitral Valve Chords,” The Heart Surgery Forum #2005-1005, 8 (3) (2005).
Dictionary.com definition of “lock”, Jul. 29, 2013.
Dieter RS, “Percutaneous valve repair: Update on mitral regurgitation and endovascular approaches to the mitral valve,” Applications in Imaging, Cardiac Interventions, Supported by an educational grant from Amersham Health pp. 11-14 (2003).
Elliott, Daniel S., Gerald W. Timm, and David M. Barrett. “An implantable mechanical urinary sphincter: a new nonhydraulic design concept.” Urology52.6 (1998): 1151-1154.
Langer et al. Ring plus String: Papillary muscle repositioning as an adjunctive repair technique for ischemic mitral regurgitation, The Journal of Thoracic Cardiovascular surgery vol. 133 No. 1, Jan. 2007.
Langer et al. Ring+String, Successful Repair technique for ischernic mitral regurgitation with severe leaflet Tethering, The Department of Thoracic Cardiovascular surgery, Hamburg, Germany, Nov. 2008.
Maisano, “The double-orifice technique as a standardized approach to treat mitral,” European Journal of Cardio-thoracic Surgery 17 (2000) 201-205.
O'Reilly S et al., “Heart valve surgery pushes the envelope,” Medtech Insight 8(3): 73, 99-108 (2006).
Odell JA et al., “Early Results o4yf a Simplified Method of Mitral Valve Annuloplasty,” Circulation 92:150-154 (1995).
Park, Sang C. et al. “A percutaneously adjustable device for banding of the pulmonary trunk.” International journal of cardiology 9.4 (1985): 477-484.
Swain CP et al., “An endoscopically deliverable tissue-transfixing device for securing biosensors in the gastrointestinal tract,” Gastrointestinal Endoscopy 40(6): 730-734 (1994).
Swenson, O. An experimental implantable urinary sphincter. Invest Urol. Sep. 1976;14(2):100-3.
Swenson, O. and Malinin, T.I., 1978. An improved mechanical device for control of urinary incontinence. Investigative urology, 15(5), pp. 389-391.
Swenson, Orvar. “Internal device for control of urinary incontinence.” Journal of pediatric surgery 7.5 (1972): 542-545.
Tajik, Abdul, “Two dimensional real-time ultrasonic imaging of the heart and great vessels”, Mayo Clin Proc. vol. 53:271-303, 1978.
Related Publications (1)
Number Date Country
20210038378 A1 Feb 2021 US
Provisional Applications (1)
Number Date Country
62272871 Dec 2015 US
Divisions (1)
Number Date Country
Parent 15393809 Dec 2016 US
Child 17083127 US